Diarrhea - Pipeline Review, H2 2017

  • ID: 4330519
  • Report
  • Region: Global
  • 146 Pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Actelion Ltd
  • Ardelyx Inc
  • DiscoveryBiomed Inc
  • Nippon Shinyaku Co Ltd
  • Rebiotix Inc
  • Sigmoid Pharma Ltd
  • MORE
Diarrhea - Pipeline Review, H2 2017

Summary:

The latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Pipeline Review, H2 2017, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.

Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.

Report Highlights:

The latest Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 7, 10, 2, 1, 21 and 4 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 2 and 4 molecules, respectively.

Diarrhea (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Diarrhea (Gastrointestinal).
  • The pipeline guide reviews pipeline therapeutics for Diarrhea (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Diarrhea (Gastrointestinal) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Diarrhea (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Diarrhea (Gastrointestinal)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Diarrhea (Gastrointestinal).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Diarrhea (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Actelion Ltd
  • Ardelyx Inc
  • DiscoveryBiomed Inc
  • Nippon Shinyaku Co Ltd
  • Rebiotix Inc
  • Sigmoid Pharma Ltd
  • MORE
Introduction

Diarrhea - Overview

Diarrhea - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Diarrhea - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Diarrhea - Companies Involved in Therapeutics Development

A. Menarini Industrie Farmaceutiche Riunite Srl

Actelion Ltd

Aegis Therapeutics LLC

Akthelia Pharmaceuticals Ltd

Albireo Pharma Inc

Allergan Plc

Anatara Lifesciences Limited

Ardelyx Inc

Assembly Biosciences Inc

AzurRx BioPharma Inc

Bharat Biotech International Ltd

Cosmo Pharmaceuticals NV

DiscoveryBiomed Inc

GP Pharm SA

Miyarisan Pharmaceutical Company Ltd

Mucosis BV

Napo Pharmaceuticals Inc

Nippon Shinyaku Co Ltd

Novartis AG

Pfizer Inc

Prokarium Ltd

Rebiotix Inc

Recce Ltd

RedHill Biopharma Ltd

RxBio Inc

Scandinavian Biopharma Holding AB

Sigmoid Pharma Ltd

Summit Therapeutics Plc

Synthetic Biologics Inc

Syntiron LLC

Tasly Pharmaceutical Group Co Ltd

Wuhan Institute of Biological Products Co Ltd

Diarrhea - Drug Profiles

ABIM-101 - Drug Profile

AKT-10081 - Drug Profile

ASP-7147 - Drug Profile

AZX-1101 - Drug Profile

Biologic for Irritable Bowel Syndrome with Diarrhea - Drug Profile

cadazolid - Drug Profile

Campylobacter jejuni [strain CPS81-176] vaccine - Drug Profile

CBM-588 - Drug Profile

cholestyramine - Drug Profile

crofelemer DR - Drug Profile

Drugs for Irritable Bowel Syndrome with Diarrhea - Drug Profile

Escherichia coli vaccine - Drug Profile

ETEC vaccine - Drug Profile

ETEC vaccine - Drug Profile

Etvax - Drug Profile

GXG-8 - Drug Profile

ibodutant - Drug Profile

IMSUTMR-1501 - Drug Profile

infectious diarrhea [serotype H11] vaccine - Drug Profile

LJN-452 - Drug Profile

octreotide acetate - Drug Profile

octreotide acetate MAR - Drug Profile

ondansetron hydrochloride CR - Drug Profile

ORP-101 - Drug Profile

Peptide to Activate NHE-3 for Diarrhea - Drug Profile

PF-06425090 - Drug Profile

prulifloxacin - Drug Profile

PZ-7475 - Drug Profile

RBX-2660 - Drug Profile

RDX-023 - Drug Profile

RDX-98940 - Drug Profile

RECCE-355 - Drug Profile

Recombinant Enzyme for Diarrhea - Drug Profile

ribaxamase - Drug Profile

ridinilazole - Drug Profile

rifamycin CR - Drug Profile

Rotavac-5C - Drug Profile

rotavirus [serotypes G1, G2, G3, G4, G8, G9] (hexavalent) vaccine - Drug Profile

Rx-100 - Drug Profile

Small Molecule for Infectious Diarrhea and Necrotizing Enterocolitis - Drug Profile

Small Molecule to Inhibit EnaC and CFTR for Cystic Fibrosis, Secretory Diarrhea and Autosomal Dominant Polycystic Kidney Disease - Drug Profile

Small Molecules to Inhibit Beta-Glucuronidase for Chemotherapy Induced Diarrhea - Drug Profile

SYN-006 - Drug Profile

SYN-007 - Drug Profile

thuricin CD - Drug Profile

Typhetec - Drug Profile

Vaccine 1 for Diarrhea - Drug Profile

Vaccine 2 for Diarrhea - Drug Profile

Vaccine for Traveler's Diarrhea - Drug Profile

Vaccine for Traveler's Diarrhea - Drug Profile

Yersinia pestis vaccine - Drug Profile

Diarrhea - Dormant Projects

Diarrhea - Discontinued Products

Diarrhea - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Number of Products under Development for Diarrhea, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Companies, H2 2017 (Contd..1), H2

Number of Products under Development by Companies, H2 2017 (Contd..2), H2

Number of Products under Development by Universities/Institutes, H2

Products under Development by Companies, H2

Products under Development by Companies, H2 2017 (Contd..1), H2

Products under Development by Companies, H2 2017 (Contd..2), H2

Products under Development by Universities/Institutes, H2

Number of Products by Stage and Target, H2

Number of Products by Stage and Target, H2 2017 (Contd..1), H2

Number of Products by Stage and Mechanism of Action, H2

Number of Products by Stage and Route of Administration, H2

Number of Products by Stage and Molecule Type, H2

Diarrhea - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H2

Diarrhea - Pipeline by Actelion Ltd, H2

Diarrhea - Pipeline by Aegis Therapeutics LLC, H2

Diarrhea - Pipeline by Akthelia Pharmaceuticals Ltd, H2

Diarrhea - Pipeline by Albireo Pharma Inc, H2

Diarrhea - Pipeline by Allergan Plc, H2

Diarrhea - Pipeline by Anatara Lifesciences Limited, H2

Diarrhea - Pipeline by Ardelyx Inc, H2

Diarrhea - Pipeline by Assembly Biosciences Inc, H2

Diarrhea - Pipeline by AzurRx BioPharma Inc, H2

Diarrhea - Pipeline by Bharat Biotech International Ltd, H2

Diarrhea - Pipeline by Cosmo Pharmaceuticals NV, H2

Diarrhea - Pipeline by DiscoveryBiomed Inc, H2

Diarrhea - Pipeline by GP Pharm SA, H2

Diarrhea - Pipeline by Miyarisan Pharmaceutical Company Ltd, H2

Diarrhea - Pipeline by Mucosis BV, H2

Diarrhea - Pipeline by Napo Pharmaceuticals Inc, H2

Diarrhea - Pipeline by Nippon Shinyaku Co Ltd, H2

Diarrhea - Pipeline by Novartis AG, H2

Diarrhea - Pipeline by Pfizer Inc, H2

Diarrhea - Pipeline by Prokarium Ltd, H2

Diarrhea - Pipeline by Rebiotix Inc, H2

Diarrhea - Pipeline by Recce Ltd, H2

Diarrhea - Pipeline by RedHill Biopharma Ltd, H2

Diarrhea - Pipeline by RxBio Inc, H2

Diarrhea - Pipeline by Scandinavian Biopharma Holding AB, H2

Diarrhea - Pipeline by Sigmoid Pharma Ltd, H2

Diarrhea - Pipeline by Summit Therapeutics Plc, H2

Diarrhea - Pipeline by Synthetic Biologics Inc, H2

Diarrhea - Pipeline by Syntiron LLC, H2

Diarrhea - Pipeline by Tasly Pharmaceutical Group Co Ltd, H2

Diarrhea - Pipeline by Wuhan Institute of Biological Products Co Ltd, H2

Diarrhea - Dormant Projects, H2

Diarrhea - Dormant Projects, H2 2017 (Contd..1), H2

Diarrhea - Dormant Projects, H2 2017 (Contd..2), H2

Diarrhea - Discontinued Products, H2

List of Figures:

Number of Products under Development for Diarrhea, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Universities/Institutes, H2

Number of Products by Top 10 Targets, H2

Number of Products by Stage and Top 10 Targets, H2

Number of Products by Top 10 Mechanism of Actions, H2

Number of Products by Stage and Top 10 Mechanism of Actions, H2

Number of Products by Routes of Administration, H2

Number of Products by Stage and Routes of Administration, H2

Number of Products by Top 10 Molecule Types, H2

Number of Products by Stage and Top 10 Molecule Types, H
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Actelion Ltd
  • Aegis Therapeutics LLC
  • Akthelia Pharmaceuticals Ltd
  • Albireo Pharma Inc
  • Allergan Plc
  • Anatara Lifesciences Limited
  • Ardelyx Inc
  • Assembly Biosciences Inc
  • AzurRx BioPharma Inc
  • Bharat Biotech International Ltd
  • Cosmo Pharmaceuticals NV
  • DiscoveryBiomed Inc
  • GP Pharm SA
  • Miyarisan Pharmaceutical Company Ltd
  • Mucosis BV
  • Napo Pharmaceuticals Inc
  • Nippon Shinyaku Co Ltd
  • Novartis AG
  • Pfizer Inc
  • Prokarium Ltd
  • Rebiotix Inc
  • Recce Ltd
  • RedHill Biopharma Ltd
  • RxBio Inc
  • Scandinavian Biopharma Holding AB
  • Sigmoid Pharma Ltd
  • Summit Therapeutics Plc
  • Synthetic Biologics Inc
  • Syntiron LLC
  • Tasly Pharmaceutical Group Co Ltd
  • Wuhan Institute of Biological Products Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll